IP Library Granted Patent US 11,123,091
Granted Patent B2
US 11,123,091 · App. 15/415,465 · Granted Sep 21, 2021

Device and methods for treating paranasal sinus conditions

Inventors: Donald J. Eaton (Los Altos, CA); Thomas R. Tice (Indian Springs, AL); David B. Downie (Cupertino, CA); Patrick A. Arensdorf (Palo Alto, CA); Rodney A. Brenneman (San Juan Capistrano, CA); Danielle L. Clay (Hoover, AL)
Assignee: Intersect ENT, Inc.
A61B17/24A61K9/0043A61K9/70A61K31/573A61K31/58A61K47/14A61K47/34A61M29/00A61F2/186A61K9/1647
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,091
App. No.
15/415,465
Granted
Sep 21, 2021
Kind
B2
Abstract

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus condition. Exemplary paranasal sinus conditions are sinus inflammation due to functional endoscopic sinus surgery (FESS) and rhinosinusitis.

Claims (15)

1. A paranasal sinus device comprising:

a bioabsorbable expandable cavity member having a proximal end and a distal end, and sized and shaped to fit within a paranasal sinus cavity, wherein the expandable cavity member comprises a pronged structure comprising three or more filaments that are pliable and partially curved, and which_flex radially outwardly to contact sinus mucosa, each of the three or more filaments having a length between about 2 cm and about 5 cm, a proximal end, and a distal end, wherein the distal ends are free distal ends, and wherein the free distal ends define the distal end of the cavity member, and further wherein the expandable cavity member is self-expanding.

2. The paranasal sinus device of claim 1 , wherein the expandable cavity member is configured to biodegrade.

3. The paranasal sinus device of claim 2 , wherein the expandable cavity member comprises one or more biodegradable polymers.

4. The paranasal sinus device of claim 1 , wherein the expandable cavity member is configured to release one or more active agents.

5. The paranasal sinus device of claim 4 , wherein the one or more active agents comprises mometasone furoate.

6. The paranasal sinus device of claim 1 , wherein the expandable cavity member comprises one or more radiopaque markers.

7. The paranasal sinus device of claim 1 , further comprising one or more anchoring elements on each filament, wherein the anchoring elements are configured to anchor the expandable cavity member within the paranasal sinus cavity.

8. The paranasal sinus device of claim 1 , wherein each filament is formed from an extruded polymer.

9. A paranasal sinus device comprising:

a bioabsorbable expandable cavity member having a proximal end and a distal end, and sized and shaped to fit within a paranasal sinus cavity, wherein the expandable cavity member comprises a pronged structure comprising a plurality of filaments that are pliable and partially curved, and which flex radially outwardly to contact sinus mucosa, each filament of the plurality of filaments having a length between about 2 cm and about 5 cm, a proximal end, and a free distal tip, wherein the free distal tips define the distal end of the cavity member, and

further wherein the expandable cavity member is self-expanding.

10. The paranasal sinus device of claim 9 , wherein the expandable cavity member comprises one or more biodegradable polymers.

11. The paranasal sinus device of claim 9 , wherein the expandable cavity member is configured to release one or more active agents.

12. The paranasal sinus device of claim 11 , wherein the one or more active agents comprises mometasone furoate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2017
From: EATON, DONALD J.; TICE, THOMAS R.; DOWNIE, DAVID B.; ARENSDORF, PATRICK A.; BRENNEMAN, RODNEY; BIGGS, DANIELLE L.
To: SINEXUS, INC.
Reel/Frame 041097/0734 →
CHANGE OF NAME Recorded Jan 26, 2017
From: SINEXUS, INC.
To: INTERSECT ENT, INC.
Reel/Frame 041513/0080 →
Continuity (4)
Continuation 12883087 · Sep 15, 2010
Continuation 11398342 · Apr 4, 2006
Provisional Application 60668569 · Apr 4, 2005
Related Publication 20170128093A1 · May 11, 2017